Xolremdi

Medicinal product

(Invented) name

Xolremdi

Active substance (s)

Mavoriksaforas

Strength

100 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L03AX24, mavorixafor

Marketing authorisation holder

X4 Pharmaceuticals (Austria) GmbH, Austrija

Date of authorisation

2026-04-27

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Mavoriksaforas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120683	106790	1106790	buteliukas	N60		Receptinis	EU/1/26/2017/001	Netiekiama	-	-	No	-	-
120684	106792	1106792	buteliukas	N90		Receptinis	EU/1/26/2017/002	Netiekiama	-	-	No	-	-
120685	106793	1106793	buteliukas	N120		Receptinis	EU/1/26/2017/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-04-27	Registruotas